Tucson, AZNCT06003166Now EnrollingIRB Ready

Peripheral Nerve Injury Clinical Trial in Tucson, AZ

Access cutting-edge peripheral nerve injury treatment through this phase 2 clinical trial at a research site in Tucson. Study-provided care at no cost to qualified participants.

Sponsored by University of Arizona

Quick Self-Assessment

See if you qualify for this Tucson location

Preparing your pre-screening questions…

Expert Care in Tucson

Access peripheral nerve injury specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related peripheral nerve injury treatment provided free

Apply for This Tucson Location

Check if you qualify for this peripheral nerve injury clinical trial in Tucson, AZ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Tucson

    Convenient for AZ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Tucson site if eligible
  4. 4Begin participation

About This Peripheral Nerve Injury Study in Tucson

The purpose of this study is to evaluate the role of single dose 4-aminopyridine (4-AP) on the diagnosis of severing vs non-severing nerve injury after peripheral nerve traction and/or crush injury. The investigational treatment will be used to test the hypothesis that 4-aminopyridine can speed the determination of nerve continuity after peripheral nerve traction and/or crush injuries allowing the identification of incomplete injuries earlier than standard electrodiagnostic (EDX) and clinical assessment. Participants will be randomized to one of two groups to determine the order of treatment they receive (drug and placebo vs placebo and drug). Participants will undergo baseline testing for nerve assessment, receive either drug or placebo based on randomization and undergo hourly sensory and motor evaluation, EDX testing and serum 4AP levels for three hours after dosing. Participants will then repeat this with the crossover arm.

Sponsor: University of Arizona

Who Can Participate

Inclusion Criteria

Patients with trauma involving two or less limbs where the continuity of a given peripheral nerve or nerves is unclear on presenting physical examination.
Closed soft tissue envelope obscuring direct observation of the continuity of the affected nerve.
Cognitive ability to report sensory and motor deficit during examination.
Eligible for standard of care plan of monitoring vs surgical exploration of the nerve.
Adults subject aged 18-90
Known limb trauma which resulted in nerve injury (aim 1) or post-operative/post intervention nerve injury (aim 2).
Ability to give written informed consent.
Availability for all testing days and main trial day.

Exclusion Criteria

Distracting injury which prevents adequate examination.
Plan for surgical exploration of the nerve during the ensuing 48 hours.
Plan for surgical exploration of the nerve as part of another surgical procedure within 48 hours of evaluation.
Intoxication during examination or evidence of cognitive deficit that emerges during examination.
History of multiple sclerosis, stroke or any other diagnosed neurological disorder
History of hypersensitivity to AMPYRA® or 4-aminopyridine
Current use of aminopyridine medications, including other compounded 4-AP
Renal impairment based on calculated GFR (GFR\<80 mL/min). This laboratory value is measured in all inpatient trauma patients as part of the standard of care.
History of difficult compliance with timely follow up or plan to seek care at another institution closer to home.
Patients outside the age range or unable to consent.
Patients with a known history of a seizure disorder (4AP overdose can, in selected cases, result in limited seizure activity).
Patients with a concomitant traumatic brain injury.
Patients unable to communicate return or loss of sensation.
Patients unable to exhibit motor control on the affected limb at baseline.
Patients unwilling to complete the study requirements.
Patients with injuries too extensive to isolate a single nerve(s) for testing.
Patients currently taking organic cat-ion transporter 2 (OCT2) inhibitors, e.g. Cimetidine.
Pregnancy, breastfeeding or incarcerated individuals.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Tucson?

Yes, this clinical trial (NCT06003166) has an active research site in Tucson, AZ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Peripheral Nerve Injury Treatment Options in Tucson, AZ

If you're searching for peripheral nerve injury treatment options in Tucson, AZ, this clinical trial (NCT06003166) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Tucson research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced peripheral nerve injury specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all peripheral nerve injury clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Tucson, AZ

See all pulmonary embolism clinical trials recruiting in Tucson — not just this study.

Browse Pulmonary Embolism Trials in Tucson →

Ready to Join in Tucson?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Tucson, AZ